$153 Million is the total value of Knoll Capital Management, LLC's 39 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 38.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Sell | Biohaven Pharmactl Hldg Co L | $58,565,000 | -20.3% | 856,844 | -0.1% | 38.16% | -23.9% |
| APLT | Buy | Applied Therapeutics Inc | $19,227,000 | +2.5% | 1,025,464 | +20.4% | 12.53% | -2.0% |
| CRBP | Corbus Pharmaceuticals HLDGS | $9,940,000 | +57.6% | 5,045,870 | 0.0% | 6.48% | +50.6% | |
| ORGS | Orgenesis, Inc. | $7,543,000 | +27.3% | 1,316,364 | 0.0% | 4.91% | +21.7% | |
| ENTX | Buy | Entera Bio Ltd | $6,825,000 | +262.8% | 1,791,363 | +2.9% | 4.45% | +246.8% |
| ALDX | Aldeyra Therapeutics Inc | $6,765,000 | +73.2% | 569,405 | 0.0% | 4.41% | +65.5% | |
| EIGR | Eiger Biopharmaceuticals Inc | $6,144,000 | -28.0% | 694,232 | 0.0% | 4.00% | -31.2% | |
| ABEO | Abeona Therapeutics Inc | $5,376,000 | +19.7% | 2,859,767 | 0.0% | 3.50% | +14.4% | |
| New | Anavex Life Sciemves Corp | $3,151,000 | – | 210,789 | +100.0% | 2.05% | – | |
| BX | Blackstone Group LP | $2,981,000 | +15.0% | 40,000 | 0.0% | 1.94% | +9.9% | |
| LUMN | Lumen Technologies Inc | $2,937,000 | +36.9% | 220,000 | 0.0% | 1.91% | +30.8% | |
| XCUR | Exicure | $2,786,000 | +23.2% | 1,277,777 | 0.0% | 1.82% | +17.7% | |
| DOW | Dow Inc | $1,922,000 | +15.4% | 30,000 | 0.0% | 1.25% | +10.3% | |
| CTVA | Corteva Inc | $1,399,000 | +20.4% | 30,000 | 0.0% | 0.91% | +15.0% | |
| SNGX | Soligenix Inc. | $1,205,000 | +19.5% | 787,830 | 0.0% | 0.78% | +14.3% | |
| MO | New | Altria Group Inc | $1,161,000 | – | 22,700 | +100.0% | 0.76% | – |
| DD | Dupont de Nemours Inc | $1,159,000 | +8.6% | 15,000 | 0.0% | 0.76% | +3.9% | |
| GLW | New | Corning Inc | $1,157,000 | – | 26,600 | +100.0% | 0.75% | – |
| CVS | New | CVS Health Corp | $1,091,000 | – | 14,500 | +100.0% | 0.71% | – |
| ANGN | New | Angion BioMedica Corp | $1,084,000 | – | 60,000 | +100.0% | 0.71% | – |
| BAH | New | Booz Allen Hamilton HLDG CORcl a | $1,047,000 | – | 13,000 | +100.0% | 0.68% | – |
| VMW | New | VMWare Inc | $1,046,000 | – | 6,950 | +100.0% | 0.68% | – |
| ANET | New | Arista Networks Inc | $1,041,000 | – | 3,450 | +100.0% | 0.68% | – |
| V | New | Visa | $1,027,000 | – | 4,850 | +100.0% | 0.67% | – |
| TMO | New | Thermo Fischer Scientific Inc | $958,000 | – | 2,100 | +100.0% | 0.62% | – |
| BTAI | BioXCel Therapeutics Inc | $863,000 | -6.6% | 20,000 | 0.0% | 0.56% | -10.8% | |
| ALT | Altimmune Inc | $707,000 | +25.4% | 50,000 | 0.0% | 0.46% | +19.7% | |
| MMX | MAVERIX METALS INC | $606,000 | -3.5% | 115,000 | 0.0% | 0.40% | -7.7% | |
| SA | SEABRIDGE GOLD INC | $517,000 | -23.3% | 32,000 | 0.0% | 0.34% | -26.7% | |
| FNV | FRANCO NEV CORP | $470,000 | 0.0% | 3,750 | 0.0% | 0.31% | -4.4% | |
| OR | OSISKO GOLD ROYALTIES LTD | $448,000 | -18.7% | 190,000 | 0.0% | 0.29% | -22.3% | |
| AEM | AGNICO EAGLE MINES LTD | $399,000 | -18.1% | 6,900 | 0.0% | 0.26% | -21.7% | |
| EQX | EQUINOX GOLD CORP | $364,000 | -22.6% | 45,500 | 0.0% | 0.24% | -25.9% | |
| KL | KIRKLAND LAKE GOLD LTD | $363,000 | -18.2% | 10,750 | 0.0% | 0.24% | -22.1% | |
| FSM | FORTUNA SILVER MINES INC | $283,000 | -21.4% | 43,700 | 0.0% | 0.18% | -24.9% | |
| MAG | MAG SILVER CORP | $260,000 | -26.8% | 17,300 | 0.0% | 0.17% | -30.2% | |
| SILV | SILVERCREST METALS INC | $250,000 | -28.0% | 31,000 | 0.0% | 0.16% | -31.2% | |
| PAAS | PAN AMERN SILVER CORP | $246,000 | -13.1% | 8,200 | 0.0% | 0.16% | -17.1% | |
| SVM | SILVERCORP METALS INC | $179,000 | -26.6% | 36,500 | 0.0% | 0.12% | -29.5% | |
| MTEM | Exit | Molecular Templates | $0 | – | -113,905 | -100.0% | -0.73% | – |
| AVXL | Exit | Anavex Life Sciences Corp | $0 | – | -670,789 | -100.0% | -2.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-06-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Aldeyra Therapeutics Inc | 35 | Q3 2023 | 31.6% |
| Corbus Pharmaceuticals HLDGS | 30 | Q3 2022 | 46.5% |
| Abeona Therapeutics Inc | 30 | Q3 2022 | 34.8% |
| Biohaven Pharmactl Hldg Co L | 26 | Q3 2023 | 79.6% |
| Entera Bio Ltd | 22 | Q3 2023 | 7.8% |
| Ampio Pharmaceuticals Inc. | 21 | Q2 2018 | 11.0% |
| Soligenix Inc. | 20 | Q3 2022 | 1.7% |
| Eiger Biopharmaceuticals Inc | 19 | Q3 2022 | 5.8% |
| Applied Therapeutics Inc | 18 | Q3 2023 | 19.7% |
| Alcobra Ltd | 18 | Q3 2017 | 6.5% |
View Knoll Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HOOKIPA Pharma Inc. | June 20, 2023 | 5,517,385 | 6.8% |
| Applied Therapeutics Inc. | January 23, 2023 | 3,450,000 | 7.2% |
| Orgenesis Inc. | August 14, 2020 | 1,316,364 | 5.9% |
| Corbus Pharmaceuticals Holdings, Inc. | February 14, 2020 | 5,045,870 | 7.1% |
| ABEONA THERAPEUTICS INC. | February 14, 2018 | 2,359,767 | 5.0% |
| SOLIGENIX, INC. | November 13, 2017 | 870,000 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2017 | 2,359,767 | 5.9% |
| ALCOBRA LTD. | February 14, 2017 | 1,205,498 | 4.4% |
| Ampio Pharmaceuticals, Inc. | February 14, 2017 | 2,738,322 | 4.8% |
| RITTER PHARMACEUTICALS INC | February 14, 2017 | 952,434 | 8.2% |
View Knoll Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-04 |
| 13F-HR | 2023-08-15 |
| SC 13G | 2023-06-20 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
View Knoll Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.